LuciLena Injection
Lenacapavir
- Concentración
- 463.5 mg/ 1.5 ml
- Fabricante
- Lucius Pharma
- Disponibilidad
- Disponible para obtener
Lenacapavir 463.5 mg/ 1.5 ml — Injection, 1's Vial
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Sunlenca by Gilead Sciences, Inc · Manufacturer: Lucius Pharma. Indication & Dosage: LuciLena Injection (Lenacapavir), generic Sunlenca is a prescription medicine used to treat of multidrug-resistant HIV-1 infection in heavily treatment-experienced adults whose current antiretroviral regimen is failing due to drug resistance, intolerance, or safety-related issues. LuciLena Injection manufactured by Lucius Pharma Ltd. In Laos. Lenacapavir Injection has to be given as a subcutaneous injection every 6 months for ongoing treatment. Side Effects: The most common side effects of Lenacapavir are: Headache, dizziness, sore throat, Nausea. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
